|Articles|April 1, 2004
Neoangiogenesis may be most critical marker for melanoma patient prognosis
Washington - Ongoing research indicates neoangiogenesis may have a role as both a novel, powerful prognostic factor for melanoma and an important target for therapeutic strategies aiming to reduce the risk for metastasis, said Robert J. Friedman, M.D., M.Sc.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
New Clinical Insights Into Hair Loss Disorders and the Vitamin D Receptor
3
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
4
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
5














